vai alle Pubblicazioni
Pubblicazioni antecedenti il 2004
Recent publications:
1: Salvo F, Raschi E, Moretti U, Chiarolanza A, Fourrier-Réglat A,
Moore N, Sturkemboom M, De Ponti F, Poluzzi E, Pariente A.
Pharmacological prioritisation of signals of disproportionate
reporting: proposal of an algorithm and pilot evaluation. Eur J
Clin Pharmacol. 2014 2014 May;70(5):617-25.
2: Raschi E, Poluzzi E, Godman B, Koci A, Moretti U, Kalaba M,
Bennie M, Barbui C, Wettermark B, Sturkenboom M, De Ponti F.
Torsadogenic risk of antipsychotics: combining adverse event
reports with drug utilization data across Europe. PLoS One. 2013
Nov 20;8(11):e81208.
3: Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De
Ponti F. Phytoestrogens in postmenopause: the state of the art from
a chemical, pharmacological and regulatory perspective. Curr Med
Chem. 2014;21(4):417-36.
4: Roberto G, Piccinni C, D'Alessandro R, Poluzzi E. Triptans and
serious adverse vascular events: data mining of the FDA Adverse
Event Reporting System database. Cephalalgia. 2014
Jan;34(1):5-13.
5: Poluzzi E, Piccinni C, Sangiorgi E, Clo M, Tarricone I,
Menchetti M, De Ponti F. Trend in SSRI-SNRI antidepressants
prescription over a 6-year period and predictors of poor adherence.
Eur J Clin Pharmacol. 2013 Dec;69(12):2095-101.
6: Poluzzi E, Raschi E, Koci A, Moretti U, Spina E, Behr ER,
Sturkenboom M, De Ponti F. Antipsychotics and torsadogenic risk:
signals emerging from the US FDA Adverse Event Reporting System
database. Drug Saf. 2013 Jun;36(6):467-79.